Elizabeth Berry-Kravis to Drug Evaluation, Preclinical
This is a "connection" page, showing publications Elizabeth Berry-Kravis has written about Drug Evaluation, Preclinical.
Connection Strength
0.150
-
Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome. Nat Rev Drug Discov. 2018 04; 17(4):280-299.
Score: 0.150